# Wai Danny

> Wai Danny is a startup investor at Fosun Pharma. See 0 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Fosun Pharma](https://shizune.co/investors/profile/fosun-pharmaceutical)
- Last updated: Aug 2026

Wai Danny is a startup investor at Fosun Pharma. Mr. Wai born in 1963 and has a master’s degree. Mr. Wai was appointed as the Company’s Independent non-executive Director on June 2016.Mr. Wai served as an Analyst and Senior Analyst of The MAC Group, Inc. (Hong Kong) (now part of The Capgemini Group) from 1987 to 1990, as the Financial Analyst of Postal Buddy Corporation from 1992 to 1994,various positions as Director, Assistant Director, Manager, Assistant Manager and Executive in the Corporate Finance Department of Jardine Fleming Holdings Ltd. (now part of JP Morgan Chase & Co.) from 1994 to 2001, as a Vice President in the Global Mergers & Acquisitions Group of JP Morgan Chase & Co. (Hong Kong) from 2001 to 2002, and as Executive Director, Managing Director and Head of Asia in the Global Healthcare Group of the Investment Banking Department, UBS AG (Hong Kong Branch) during the period from 2004 to 2007 and the period from 2007 to 2015, respectively.

## About Fosun Pharma

VC Fund · Shanghai, China

Fosun Pharma is a biopharmaceutical and healthcare industry. Fosun Pharma has captured opportunities within the rapidly developing Chinese healthcare industry as well as from the globalization of Chinese healthcare companies in general. Fosun Pharma's operations strategically cover several important segments of the healthcare industryvalue-chain, including: pharmaceutical manufacturing, distribution and retail.

5 contacts available at Fosun Pharma.

| Name | Title | Profile |
| --- | --- | --- |
| Cui Zhiping | Vice President and General Manager of VC Investment Department | https://shizune.co/investors/profile/cui-zhiping |
| Hongfei Jia | SVP, Joint Chief Investment Officer and General Manager of International Operations Department | https://shizune.co/investors/profile/hongfei-jia |
| Wai Danny | Independent Non-Executive Director | https://shizune.co/investors/profile/wai-danny |
| Wu Yifang | Senior vice president and Chief operating officer | https://shizune.co/investors/profile/wu-yifang |
| Zhou Biao | SVP, General Manager of Legal Department and General Manager of Independent Inspectors Department | https://shizune.co/investors/profile/zhou-biao |

## FAQ

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co